(Q46697253)

24 December 2017

title

Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction (English)

1 reference

24 December 2017

Olsalazine and 6-mercaptopurine-related bone marrow suppression: A possible drug-drug interaction (English)

1 reference

https://api.crossref.org/works/10.1016/S0009-9236(97)90125-9

22 November 2024

0 references

1 reference

0 references

6

Weinshilboum RM

1 reference

24 December 2017

L. D. Lewis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9357398

22 November 2024

A. Benin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9357398

22 November 2024

C. L. Szumlanski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9357398

22 November 2024

D. M. Otterness

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9357398

22 November 2024

L. Lennard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9357398

22 November 2024

R. M. Weinshilboum

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9357398

22 November 2024

D. W. Nierenberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9357398

22 November 2024

language of work or name

English

0 references

publication date

1 October 1997

1 reference

24 December 2017

October 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9357398

Clinical Pharmacology & Therapeutics

22 November 2024

published in

1 reference

24 December 2017

volume

62

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

464-475

1 reference

24 December 2017

Inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Human kidney thiopurine methyltransferase. Purification and biochemical properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6‐mercaptopurine and azathioprine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Statistical estimations in enzyme kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Computer Programmes for Processing Enzyme Kinetic Data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Intraindividual variability in red blood cell thiopurine methyltransferase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Comparative bioavailability of 5-aminosalicylic acid from a controlled release preparation and an azo-bond preparation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

Distribution of xanthine oxidoreductase activity in human tissues--a histochemical and biochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990125-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Molecular Pharmacology

18

24

471

Woodson L. C.

1994

1 reference

https://api.crossref.org/works/10.1016/S0009-9236(97)90125-9

22 November 2024

Molecular Pharmacology

21

43

878

Honchel R.

1993

1 reference

https://api.crossref.org/works/10.1016/S0009-9236(97)90125-9

22 November 2024

Identifiers

1 reference

24 December 2017

1 reference

24 December 2017